A bacterioferritin (BFR) deletion mutant of Brucella melitensis 16M was generated by gene replacement. The deletion was complemented with a broad-host-range vector carrying the wild-type bfr gene, pBBR-bfr. The survival and growth of the mutant, B. melitensis PAD 2-78, were similar to those of its parental strain in human monocyte-derived macrophages (MDM). These results suggest that BFR is not essential for the intracellular survival of B. melitensis in human MDM.
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Phagocytosis and killing by macrophages are among the initial innate defenses by the body against infectious agents; however, several bacteria including Brucella spp. are able to avoid the killing mechanisms and replicate within macrophages (11, 27) . Although many specific strategies developed by pathogens to survive and multiply within the host and within macrophages have been identified (27) , only a few mechanisms are clearly known to be used by brucellae (5, 6, 9, 17, 25) .
Iron is an essential element, but it can be toxic in excess. Most microorganisms have developed transport and storage systems for the uptake and the deposition of this element in an intracellular nontoxic form. Iron metabolism is considered to play a central role in virulence, and a mechanism to scavenge iron is a requisite for microbial pathogenicity (13) . A correlation between iron metabolism and the virulence of Brucella spp. has been postulated (3, 16, 32) .
The acquisition of iron by the Brucella abortus siderophore (2,3-dihydroxybenzoic acid) has been studied (19, 20) , and we have reported previously the cloning of a gene encoding the bacterioferritin (BFR) of Brucella melitensis (8) . BFR is a heme-containing iron storage multimeric protein composed of 24 identical subunits, which form a roughly spherical protein shell surrounding a central iron storage cavity (12) . The presence of BFR in a wide variety of prokaryotic organisms (1, 26, 28) , including some bacterial pathogens such as Pseudomonas aeruginosa (21) , Yersinia pestis (23) , Mycobacterium avium (14) , Mycobacterium paratuberculosis (4), and Mycobacterium leprae (24) , has been established. In M. leprae, it has been suggested that BFR could function as a temporary depository for iron during iron deprivation, a condition encountered by this bacterial species in its host (24) . Since the precise role of BFR remains to be elucidated and considering the possible correlation between iron metabolism and Brucella sp. virulence, we constructed a BFR deletion mutant of B. melitensis 16M. The survival of this mutant strain in human monocyte-derived macrophages (MDM) indicates that BFR is not essential for the intracellular survival of B. melitensis.
Characterization of B. melitensis bfr mutants. A B. melitensis bfr defined deletion mutant was constructed by gene replacement (Fig. 1A) . Plasmid pCm69 encoding BFR was described previously (8) . This plasmid contains a 3.9-kb HindIII B. melitensis DNA fragment cloned in the vector pBluescript KSϪ. Construction of the deletion plasmid used for gene replacement was done as described below with oligonucleotides purchased from Eurogentec (Liege, Belgium) and restriction endonucleases and modifying enzymes from Boehringer Mannheim. PCR amplifications were performed with a GeneE thermal cycler (Techne) and Pwo polymerase (Boehringer Mannheim). The 1.9-kb DNA region upstream of the bfr open reading frame (ORF) was obtained by PCR amplification on plasmid pCm69 with primers spB⌬ and spC⌬ (Fig. 1A) , which introduced a BamHI site and an XbaI site, respectively, in the sequence at the ends of the amplified fragment. This DNA fragment was called fragment B. The 1.5-kb DNA region downstream of the bfr ORF was obtained by PCR amplification on plasmid pCm69 with the M13 reverse primer (Stratagene) and the spA⌬ primer (Fig. 1A) , which introduced an EcoRI site in the sequence. This fragment was called fragment A and was digested by HindIII and EcoRI; then, this fragment was ligated in the HindIII-EcoRI-digested pSKoriT vector, leading to plasmid p⌬bfrI. Fragment B was digested by BamHI and XbaI and inserted in the BamHI-XbaI-digested p⌬bfrI plasmid to generate plasmid p⌬bfrII. Finally, an EcoRI DNA fragment containing the kanamycin cassette obtained from vector pUC4K (Pharmacia) was ligated in the EcoRI-linearized p⌬bfrII plasmid. The resulting plasmid, p⌬bfr, was transferred by mobilization into B. melitensis 16M as described previously (30) .
Gene replacement candidates were isolated by selecting kanamycin-resistant, ampicillin-sensitive, recombinant clones. HindIII-digested genomic DNA from these clones and the parental strain was analyzed by Southern blot hybridization with bfr and kanamycin resistance gene probes (Fig. 1B) . Southern blotting on positively charged nylon membranes (Tropix) was performed with a Hybaid vacuum blotter (Biozym). Probes were labelled by random primer labelling with the Random Primer Fluorescein DNA labelling kit (Tropix), and detection was performed with the Southern-Star kit (Tropix).
The bfr probe hybridized to a HindIII 3.9-kb chromosomal DNA fragment from the B. melitensis 16M parental strain but not to DNA from the gene replacement candidate clones. The kanamycin resistance gene probe did not hybridize to parental strain DNA but did hybridize to 2.6-and 2.1-kb HindIII fragments from the gene replacement candidates, indicating that double crossovers between the deletion plasmid and homologous chromosomal DNA had occurred and that the kanamycin resistance gene had replaced the bfr ORF. One of these candidates, strain PAD 2-78, was used for the next experiments.
Protein profiles of B. melitensis 16M and PAD 2-78 were examined for expression of BFR by two-dimensional gel electrophoresis (29) (Fig. 2) . The spot corresponding to BFR (pI 5, 19 kDa) in B. melitensis 16M is not present in B. melitensis PAD 2-78. This observation, together with the results of the Southern hybridization experiment, clearly demonstrates that BFR is not present in mutant strain PAD 2-78 and that the bfr gene is not an essential gene.
The smooth morphology, the oxidative rate after 24 h of growth on Trypticase soy agar with different substrates, and the lysis by bacteriophages of the PAD 2-78 strain used in this study were indistinguishable from those of its parental strain (data not shown).
Complementation of the bfr deletion. A 4.2-kb HindIII B. melitensis DNA fragment containing the entire bfr gene was inserted at the HindIII site of plasmid pBBR1-MCS4, leading to plasmid pBBR-BFR. This plasmid was introduced by electroporation into the B. melitensis PAD 2-78 deletion strain following the protocol of Lai et al. (18) to create B. melitensis PAD 2-78 complemented (PAD 2-78 c-s) strain.
Sensitivity to stress response reagents. The sensitivities of B. melitensis 16M, PAD 2-78, and PAD 2-78 c-s strains to oxidative reagents were evaluated by a modification of the disk sensitivity assay (10) . The sensitivities of mutant strain PAD 2-78 to H 2 O 2 and to oxidative stress agent paraquat and redox cycling agent menadione (Sigma) were similar to those of the wild-type and PAD 2-78 c-s strains (data not shown).
Survival of B. melitensis PAD 2-78 in human MDM.
The preparation and infection of human MDM were performed as described previously (9) . Brucella cells grown in liquid for 24 h were washed in saline, resuspended in complete cell culture medium at 5 ϫ 10 8 CFU/ml, and added to MDM at a multiplicity of infection of 10:1 in the presence of 10% fresh-frozen (Ϫ70°C) normal Brucella-seronegative human serum. After 60 min, the monolayers were washed three times and either lysed immediately with 0.1% Triton X-100 or cultured with medium containing 5 g of gentamicin per ml. Triton X-100 lysates were serially diluted and plated on Brucella agar to determine bacterial CFU/culture. The data presented in Fig. 3 For the three strains tested, the numbers of viable Brucella cells in monolayers of human MDM cells were compared 1, 24, and 48 h after infection (Fig. 3) . At 1 h postinfection, the numbers of intracellular B. melitensis 16M, PAD 2-78, and PAD 2-78 c-s cells were 4.7, 4.9, and 4.8 log 10 units, respectively, indicating that the PAD 2-78 deletion strain was internalized at the same level as the parental strain. Within 48 h, the numbers of recoverable bacteria were 7.3, 7.4, and 7.0 log 10 units, respectively, indicating that intracellular growth had occurred.
Only minor differences in uptake and intracellular growth in human MDM between the BFR mutant and its parental strain were seen. The same results were obtained with and without 5 g of gentamicin per ml (data not shown). This finding indicated that the concentration of gentamicin used did not inhibit intracellular bacterial growth. In other experiments, infection of MDM with brucellae in the presence of heated (56°C, 30 min) normal serum instead of fresh-frozen serum resulted in comparable levels of intracellular growth of the two strains. Initial uptakes for both strains were reduced 3-to 10-fold compared to uptakes in the presence of fresh-frozen serum (data not shown). In contrast to these results for the deletion of bfr, results for the deletion of the purE gene from B. melitensis indicate that the deletion profoundly reduces bacterial growth in human MDM (9) .
It has been suggested that BFR is the primary repository for the iron required for mycobacterial metabolism during cell division. Thus, BFR could conserve iron for the progeny of dividing cells (22) . This does not seem to be the case for the Brucella BFR, as the BFR mutant survives and replicates as well as the wild-type strain in vitro and ex vivo in human MDM. Also, it seems likely that elimination of the BFR iron storage protein does not modify the sensitivity to oxidative damage. This may have been predicted, as it has been shown that the oxygen sensitivity of a ⌬fur ⌬recA mutant of Escherichia coli is almost completely suppressed by overexpression of the gene encoding a ferritin H-like protein (ftn) (15, 31) but not by overexpression of the bfr gene. Together with our data, these studies suggest that BFR is not important in protecting B. melitensis against oxidative and iron-generated oxidative damage.
Preliminary results were obtained with the BFR mutant in a mouse model infection (10 4 bacteria/mouse intraperitoneally). No difference in spleen colonization between the mutant and the parental strain was observed even 8 weeks after infection (number of B. melitensis 16M cells recovered ϭ 3.2 Ϯ 0.37 log 10 units; number of B. melitensis PAD 2-78 cells recovered ϭ 2.88 Ϯ 0.84 log 10 units). These preliminary data confirm our observations with human MDM.
Iron alone and in conjunction with gamma interferon has been shown to enhance the intracellular killing of B. abortus by murine macrophage cell line J774A.1 (16) . This killing could occur via the generation of hydroxyl radicals by the HaberWeiss reaction catalyzed by iron (2). However, even if the precise mechanisms remain unknown, the scavenging and withholding of iron by Brucella could inhibit the Haber-Weiss reaction. This suggestion is supported by the experiments performed with bacteria stimulated by growth in iron-deficient media. Indeed, infection of mice and guinea pigs with Brucella suis grown in media containing variable amounts of iron demonstrated that there was a tendency to greater invasiveness and more rapid multiplication of iron-deficient bacteria. For infection by such bacteria, the mononuclear inflammatory response developed more slowly and granulocytes infiltrating the site of infection were rapidly degraded (32) . Whatever the exact bacterial mechanisms underlying these observations, they are probably independent of BFR activity. BFR has been shown to be a potential antigen that could be helpful for the cellular diagnosis of brucellosis (7) . A brucellosis diagnostic test based upon the utilization of this antigen could help to discriminate infected animals from animals vaccinated with a new vaccine strain devoid of the bfr gene.
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